small molecule

MUCINEX

GUAIFENESIN

Loss of exclusivityloss of exclusivity
CompanyRB HEALTH US LLC

Drug detail

Brand nameMUCINEX
Active ingredientGUAIFENESIN
Strength600MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2002
Marketing statusOTC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

MUCINEX patent cliff — loss of exclusivity — | CliffBio